Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC) – Butlletí de la Recerca

Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)

by biblioteca on 12 de gener de 2026 with No hi ha comentaris

Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
Convoca: Pfizer Inc
Termini: 31/01/2026

Deixa un comentari Cancel·la les respostes